Holen Sie sich die Stockscreener-App
4.80
0.84%
0.04
Vorhandelsmarkt:
4.88
0.08
+1.67%
Schlusskurs vom Vortag:
$4.76
Offen:
$4.75
24-Stunden-Volumen:
605.53K
Relative Volume:
0.49
Marktkapitalisierung:
$131.60M
Einnahmen:
$160.43M
Nettoeinkommen (Verlust:
$-227.64M
KGV:
-0.0698
EPS:
-68.77
Netto-Cashflow:
$-170.79M
1W Leistung:
-10.45%
1M Leistung:
-1.23%
6M Leistung:
+37.14%
1J Leistung:
-9.09%
1-Tages-Spanne:
$4.60
$4.82
1-Wochen-Bereich:
$4.60
$5.5896
52-Wochen-Spanne:
$1.38
$7.34
Agenus Inc Stock (AGEN) Company Profile
Firmenname
Agenus Inc
Sektor
Branche
Telefon
781-674-4410
Adresse
3 FORBES ROAD, LEXINGTON, MA
Vergleichen Sie AGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
4.80 | 130.50M | 160.43M | -227.64M | -170.79M | -68.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-07-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-07-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-07-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-06 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-09-28 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-04-22 | Eingeleitet | B. Riley FBR | Buy |
| 2016-10-28 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2016-10-27 | Bestätigt | Maxim Group | Buy |
| 2016-03-11 | Hochstufung | Maxim Group | Hold → Buy |
| 2015-12-16 | Eingeleitet | Jefferies | Buy |
| 2015-10-27 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-07-27 | Bestätigt | MLV & Co | Buy |
| 2015-06-11 | Eingeleitet | Oppenheimer | Outperform |
| 2015-01-12 | Bestätigt | Maxim Group | Buy |
| 2015-01-09 | Bestätigt | MLV & Co | Buy |
| 2015-01-09 | Bestätigt | Maxim Group | Buy |
| 2014-12-19 | Bestätigt | Maxim Group | Buy |
| 2014-05-08 | Bestätigt | Maxim Group | Buy |
| 2014-03-14 | Bestätigt | MLV & Co | Buy |
| 2013-10-08 | Bestätigt | Maxim Group | Buy |
| 2012-01-05 | Eingeleitet | William Blair | Outperform |
| 2011-12-01 | Eingeleitet | Global Hunter Securities | Buy |
Alle ansehen
Agenus Inc Aktie (AGEN) Neueste Nachrichten
Is Agenus Inc. exposed to currency risksHigh Profit Stock Recommendations - kangso.co.kr
Agenus Earnings Outlook: Analysts Expect $0.50 EPS in Q2 2025 - AInvest
Can Agenus Inc. disrupt its industryHyper-Growth Screener - mustnews.co.kr
Agenus AGEN Q2 2025 Earnings Preview Upside Potential on Strategic CDMO Shift - AInvest
Examining the Future: Agenus's Earnings Outlook - 富途牛牛
Should value investors consider Agenus Inc.ROI Enhanced Trading Plan - newsyoung.net
Smart tools for monitoring Agenus Inc.’s price actionLong Term Stock Growth Plan Suggestions - Newser
Why Agenus Inc. stock attracts strong analyst attentionInsider Strategy for High Conviction Picks - Newser
Tools to monitor Agenus Inc. recovery probabilityLong-Term Stock Growth Forecast Insights - Newser
Agenus Inc. shares fall 2.41% intraday after Delhi High Court restrains Zydus Lifesciences from launching nivolumab biosimilar. - AInvest
How many analysts rate Agenus Inc. as a “Buy”Build a portfolio that outperforms the market - Jammu Links News
What institutional investors are buying Agenus Inc. stockMaximize portfolio value with expert tips - Jammu Links News
Agenus Inc. Stock Analysis and ForecastMaximize returns with strategic portfolio planning - Jammu Links News
Is Agenus Inc. a growth stock or a value stockAchieve superior returns through strategic trading - Jammu Links News
What markets is RILYL expanding into Is Agenus Inc. stock a good long term investment optionConsistently high yield - Jammu Links News
Why is Agenus Inc. stock attracting strong analyst attentionExceptional trading results - Jammu Links News
What makes Agenus Inc. stock price move sharplyCapitalize on proven investment strategies - Jammu Links News
Should I hold or sell Agenus Inc. stock in 2025Discover stocks with explosive potential - Jammu Links News
What analysts say about Agenus Inc. stockMaximize returns with strategic trading plans - Jammu Links News
How strong is Agenus Inc. company’s balance sheetAchieve rapid portfolio growth with expert guidance - Jammu Links News
Is Agenus Inc. a good long term investmentRapid wealth creation - Jammu Links News
What is the dividend policy of Agenus Inc. stockHigh-velocity capital appreciation - Jammu Links News
What are the latest earnings results for Agenus Inc.Consistently profitable trades - Jammu Links News
What are analysts’ price targets for Agenus Inc. in the next 12 monthsMarket-beating returns - Jammu Links News
Statistical indicators supporting Agenus Inc.’s strengthRetirement Investment Outlook and Return Summary - Newser
Agenus Announces Q2 2025 Financial Results, Stakeholder Briefing to Highlight Botensilimab and Balstilimab Programs - AInvest
Is Agenus Inc. stock overvalued or undervaluedEarnings Report Alerts To Watch Now - Jammu Links News
Zacks.com featured highlights include QuantumScape, Civeo and Agenus - The Globe and Mail
QuantumScape, Civeo, and Agenus Lead the Way in Earnings Acceleration - AInvest
Agenus to Provide Corporate Update and Second Quarter 2025 Financial Report - The Globe and Mail
Agenus Inc. shares rise 2.90% after-hours after announcing Q2 2025 financial results and strategic update. - AInvest
Leading vs lagging indicators on Agenus Inc. performanceAlpha Stock Picks with Chart Confirmation - Newser
Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments - Benzinga
Agenus Inc. Company’s Quarterly Earnings Growth: What the Numbers SayLow Risk Buy Zone Opportunity Watch Ongoing - metal.it
Agenus Inc. to Host Earnings Call - ACCESS Newswire
Traders Watching For Reversal Pattern in Agenus Inc.Real Time Alerts Based on AI Prediction Triggered - metal.it
Agenus Inc. Bounces Off Moving Average SupportEarly Entry Picks Before News Breakout Reviewed - metal.it
RSI Crosses Above 30 for Agenus Inc. — Reversal in SightFast Return Equity Trade Forecast Points to Small Caps - metal.it
Agenus Inc. Breaks Losing Streak — Is the Trend ReversingAI Forecast for Trending Stocks Indicates Upside - beatles.ru
What are the technical indicators suggesting about Agenus Inc.Build a diversified portfolio for stability - Jammu Links News
Will Agenus Inc. continue its uptrendHigh Yield Watchlist with Filtered Picks - Newser
What are Agenus Inc. company’s key revenue driversExponentially increasing returns - jammulinksnews.com
What markets is Agenus Inc. expanding into Is GDXU stock a good long term investment optionExplosive earning power - Jammu Links News
Finanzdaten der Agenus Inc-Aktie (AGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):